Natco Pharma shares in focus on agrochemicals demerger plan; key details
News by Aliceblue News Desk
19 Mar 2026
Introduction
Leading pharmaceutical company to consider demerger of agrochemicals division into wholly owned subsidiary at March 24 board meeting, with trading window closed from March 19 to 26.
Also Read:A B Infrabuild secures East Coast Railway infrastructure contract worth ₹48.67 Cr,
Share price movement of Natco Pharma
On March 19, 2026, Natco Pharma Ltd opened at ₹956.15, down 0.14% from its previous close of ₹957.50. The stock reached a high of ₹969.00 (1.19%) and a low of ₹932.95 (-2.54%). By 2:30 PM, it traded at ₹954.00, a -0.16% decrease, with a market cap of ₹16,783.49 crore.
Natco Pharma Demerger Plan
Natco Pharma Limited has scheduled a board meeting on March 24, 2026 to consider a scheme of arrangement for demerger of its agrochemicals division.
The proposed demerger involves transfer of the agrochemicals division into its wholly owned subsidiary, Natco Crop Health Sciences Limited, on a going concern basis as part of restructuring plan.
The trading window for company securities will remain closed from March 19 to March 26, 2026, and will reopen on March 27, 2026 as per regulations.
Stock performance of Natco Pharma for Period of 1 week, 6 months, and 1 year
Natco Pharma delivered a 1-week return of -7.69%, a 6-month return of 6.08%, and a 1-year return of 13.6%.
Also Read: Subex Ltd lands €2.7 million international project; 9-year engagement for asset management
Shareholding pattern of Natco Pharma
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
| Promoter | 49.50% | 49.50% | 49.60% |
| FII | 15.20% | 14.10% | 15.50% |
| DII | 5.40% | 5.90% | 5.80% |
| Public | 30.00% | 30.60% | 29.10% |
About Natco Pharma
Natco Pharma Ltd (NSE: NATCOPHARM) is a research-driven pharmaceutical company engaged in developing, manufacturing, and marketing complex formulations, APIs, and contract manufacturing for niche therapeutic areas.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Natco Pharma share price rising today?
A: Natco Pharma share price is rising due to its board meeting scheduled to consider the demerger of its agrochemicals division.
Q: What is Natco Pharma’s main business focus?
A: Natco Pharma’s main business focus is pharmaceuticals, with an agrochemicals division now being demerged into Natco Crop Health Sciences Limited.
Q: What are the 52-week high and low of Natco Pharma’s stock?
A: Natco Pharma’s 52-week high and low represent the stock’s peak and lowest trading prices over the past year.
News Author
Aliceblue News Desk
